WO2016106704A1 - A process for preparing a cordyceps extract - Google Patents
A process for preparing a cordyceps extract Download PDFInfo
- Publication number
- WO2016106704A1 WO2016106704A1 PCT/CN2014/095955 CN2014095955W WO2016106704A1 WO 2016106704 A1 WO2016106704 A1 WO 2016106704A1 CN 2014095955 W CN2014095955 W CN 2014095955W WO 2016106704 A1 WO2016106704 A1 WO 2016106704A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cordyceps
- minutes
- temperature
- extract
- blanching
- Prior art date
Links
- 241000190633 Cordyceps Species 0.000 title claims abstract description 149
- 238000004519 manufacturing process Methods 0.000 title description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims abstract description 88
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims abstract description 44
- 229960005305 adenosine Drugs 0.000 claims abstract description 44
- 238000000034 method Methods 0.000 claims abstract description 32
- 235000016709 nutrition Nutrition 0.000 claims abstract description 23
- 239000000203 mixture Substances 0.000 claims abstract description 22
- 238000002360 preparation method Methods 0.000 claims abstract description 14
- 206010061218 Inflammation Diseases 0.000 claims abstract description 5
- 208000024172 Cardiovascular disease Diseases 0.000 claims abstract description 4
- 230000036039 immunity Effects 0.000 claims abstract description 4
- 230000006872 improvement Effects 0.000 claims abstract description 4
- 230000004054 inflammatory process Effects 0.000 claims abstract description 4
- 230000002265 prevention Effects 0.000 claims abstract description 4
- 206010033546 Pallor Diseases 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 235000013305 food Nutrition 0.000 claims description 10
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 9
- 230000035764 nutrition Effects 0.000 claims description 9
- 238000002791 soaking Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 235000013376 functional food Nutrition 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 6
- 241001264174 Cordyceps militaris Species 0.000 claims description 4
- 235000013373 food additive Nutrition 0.000 claims description 4
- 239000002778 food additive Substances 0.000 claims description 4
- 239000002417 nutraceutical Substances 0.000 claims description 4
- 235000021436 nutraceutical agent Nutrition 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 2
- 238000003801 milling Methods 0.000 claims description 2
- 238000000643 oven drying Methods 0.000 claims description 2
- 238000001291 vacuum drying Methods 0.000 claims description 2
- 239000002002 slurry Substances 0.000 description 35
- 239000000843 powder Substances 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 4
- 241001236266 Tolypocladium ophioglossoides Species 0.000 description 4
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 4
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- 241000625793 Cordyceps pruinosa Species 0.000 description 2
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 2
- 240000001307 Myosotis scorpioides Species 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 238000011169 microbiological contamination Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 244000283482 Alloteropsis cimicina Species 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 235000017898 Digitaria ciliaris Nutrition 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- MRWXACSTFXYYMV-FDDDBJFASA-N nebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC=C2N=C1 MRWXACSTFXYYMV-FDDDBJFASA-N 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002212 purine nucleoside Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
Definitions
- the invention relates to a method for preparing a cordyceps extract. More particularly, the invention relates to a method for preparing a cordyceps extract containing adenosine in high concentration.
- Cordyceps is a genus of ascomycete fungi that grow mainly on insects and other arthropods.
- Cordyceps is a well-known ingredient in traditional Chinese medicine.
- Cordyceps is also named DongChongXiaCao in Chinese or “caterpillar fungus” or “winter worm summer grass” in English.
- the ingredient consists in fact of the fungus together with the caterpillar it developed on.
- the word “cordyceps” will refer to the traditional medicinal ingredient, as used in traditional Chinese medicine.
- the name of the species or the genus will be capitalised and in italics, such as Cordyceps sinensis.
- cordyceps is commonly used as a tonic and for medicinal purposes, such as to replenish the kidney, to soothe the lung, and for the treatment of fatigue. Because of the rarity and outstanding curative effects of Cordyceps sinensis, several strains have been isolated from wild Cordyceps sinensis mycelium. These isolated strains are used in fermentation technology and they are commonly sold as functional food products. Quality control of C. sinensis and its products is very important to ensure their safety and efficacy. In addition, some substitutes such as C. . militaris and C. adulterants also have been used.
- Cordyceps seems to be a source of interesting chemical constituents such as cordycepin (3'-de-oxyadenosine) , adenosine and its derivatives, ergosterol, or polysaccharides.
- Adenosine is a purine nucleoside and plays an important role in biochemical processes, such as energy transfer —as adenosine triphosphate (ATP) and adenosine diphosphate (ADP) —as well as in signal transduction as cyclic adenosine monophosphate (cAMP) . It is also a neuromodulator to promote sleep and suppress arousal. Adenosine also plays a role in regulation of blood flow to various organs through vasodilation. Adenosine acts through several types of receptors which are located, for instance in the immune, nervous, circulatory, respiratory or urinary systems. It is suggested that adenosine and cordycepin are some of the bio-active compounds which provide the anti-inflammation, anti-oxidant and heart-protective effects of cordyceps.
- Cordycepin (3'-deoxyadenosine) and adenosine are generally suggested as quality markers of cordyceps. Fresh cordyceps also contains high amount of water. Therefore, cordyceps must be dried for commercial purposes and long-time storage. Also, cordyceps used for food purposes must comply with regulatory requirements. For instance, in China, cordyceps products must contain at least 50 mg/100g of adenosine, and have a total plate count (TPC) below 10000.
- TPC total plate count
- Cordyceps sinensis has proven that the characteristic and nutritional components of cultured Cordyceps sinensis are the same as those of wild Cordyceps sinensis, if not higher. Additional studies showed that Cordyceps sinensis can be cultivated to produce spores which are considered as the best part of Cordyceps sinensis.
- the traditional method of preparation of cordyceps includes drying, milling, sterilising and packing.
- the cordyceps extract prepared traditionally does not provide the required adenosine content and does not meet the microbiological safety standards.
- suppliers have to be very considerate when selecting fresh cordyceps and the processing parameters.
- these operations still do not guarantee the consistency of the product, especially a reproducible batch quality.
- cordyceps extract with consistent batch quality, with sufficient adenosine content, and with a low microbiological contamination. It is also desirable that the cordyceps extract can be used easily in the preparation of food products, or beverages, such as functional food products.
- the invention provides a method for preparing a cordyceps extract comprising the steps of: a) grinding cordyceps, b) blanching said cordyceps, c) drying said blanched cordyceps, wherein blanching comprises a treatment of said cordyceps at a temperature of from 27°C to 90°C during 20 to 240 minutes in water.
- the invention provides a cordyceps extract prepared from a method according to the first aspect of the invention, wherein said cordyceps extract contains from 100 mg to 220 mg of adenosine per 100 g of extract.
- the invention provides a nutrition composition comprising a cordyceps extract obtainable by a method according to the first aspect of the invention, or a cordyceps extract according to the second aspect of the invention.
- the nutrition composition may be a food product, a drink, a functional food, a nutraceutical, a food additive, a nutritional formula, and a pet food product.
- the invention provides the use of a cordyceps extract according to the second aspect of the invention, or prepared by a method according to the first aspect of the invention, for the preparation of a nutritional composition for the treatment or prevention of fatigue, of cardiovascular disease, or of inflammation, or for the improvement of immunity.
- Figure 1 is a flow chart showing the traditional preparation of cordyceps, as explained in example 1 (prior art) .
- Figures 2 to 5 are flow charts showing embodiments of a method according to the invention, of preparing the cordyceps extract as explained in example 2 to 5.
- Figure 6 is a chromatogram of cordyceps extract by UPLC-PDA, as further explained in Experimental example 6.
- Cordyceps used herein refers to all Cordyceps species, including C. sinensis, C.militaris, C. capita, C. pruinosa and C. ophioglossoides.
- Cordyceps species are selected from the group consisting of C. sinensis, C. militaris, C.capita, C. pruinosa and C. ophioglossoides, preferably from C. sinensis, C. militaris and C. ophioglossoides.
- cordyceps extract When preparing the cordyceps extract according to the invention, a mix of cordyceps may be used, with different Cordyceps species, such as a mix of cordyceps which contains both Cordyceps sinensis and Cordyceps ophioglossoides. It is preferable that cordyceps is fresh. This way, the quality of the cordyceps extract is improved over dried cordyceps. However, it is also possible to prepare the cordyceps extract based on dried cordyceps.
- Figures 2 to 5 Examples of methods for preparing a cordyceps extract are illustrated in Figures 2 to 5. In Figures 2 to 5, optional steps are indicated in dashed boxes. Grey boxes correspond to the blanching steps, as explained below.
- cordyceps is grinded into powder. Grinding can be performed in water, to obtain a cordyceps slurry direclty. Grinding increases the surface/volume ratio of the cordyceps particle, which improves the efficiency of extraction. Grinding can be achieved by chopping, cutting, or other methods.
- the cordyceps is grinded to a particles size of 0.5mm to 5mm, more preferably of 1mm to 3mm.
- fresh cordyceps is used, although dried cordyceps can also be used.
- water is added to the grinded cordyceps, to obtain a cordyceps slurry.
- water can be also added to te cordyceps before grinding.
- the cordyceps to water weight ratio ranges from 0.5:1 to 2:1, and preferably from 1:1 to 1.5:1. If less water is used, then the extraction may be less efficient. If too much water is used with respect to the cordyceps, then it will be necessary to evaporate the excess water, which will require a higher energy input.
- Water can be distilled water or tap water. Preferably, distilled water is used to reduce the risk of microbiological contamination, especially when the cordyceps extract is not sterilized.
- the cordyceps slurry is then blanched in water.
- Blanching comprises a treatment of said cordyceps at a temperature of from 27°C to 90°C during 20 to 240 minutes in water.
- the inventors have found that blanching the cordyceps slurry improves the adenosine content of the cordyceps extract.
- the duration of the blanching step depends on the blanching temperature.
- blanching is performed in one step.
- the cordyceps slurry is blanched at a temperature of from 30°C to 85°C during 30 minutes to 200 minutes, preferably at a temperature of from 30°C to 45 °C during 120 minutes to 200 minutes.
- the cordyceps slurry is blanched by soaking at a temperature of from 30°C to 40°C during 150 minutes to 200 minutes.
- the cordyceps slurry is blanched at a temperature of from 70°Cto 90 °C during 30 minutes to 60 minutes.
- blanching is divided into two steps: a first step is a mild heat treatment, followed by a second step which is a stronger heat treatment, in water.
- a first step is a mild heat treatment
- a second step which is a stronger heat treatment, in water.
- the cordyceps slurry is first soaked at a temperature of 30°C to 45°C for 120 minutes to 200 minutes in water, then the slurry is heated to a temperature of from 70°C to 90 °C for 30 to 60 more minutes in water.
- blanching of the cordyceps slurry performed by soaking the cordyceps slurry at a first temperature of from 30°C to 45°C for 120 minutes to 200 minutes in water, then increasing the temperature up to a second temperature of 70°C to 90°C within 5 to 15 minutes, and maintaining the second temperature for 30 to 45 minutes.
- the inventors have found that soaking the cordyceps slurry for 180 min at 30°C (mild heat treatment) , and then heating the cordyceps slurry 85°C for 30 minutes (stronger heat treatment) , allows the preparation of an extract with the highest adenosine content.
- the blanched cordyceps slurry is sterilised before drying. Sterilization reduces potential contaminations and allows for an longer shelf-life of the product.
- the blanched cordyceps slurry is sterilized at a temperature of from 98°C to 101°C for 10 to 15 minutes, more preferably for about 15 minutes.
- the cordyceps slurry is dried, for instance by freeze-drying, oven-drying, or vacuum-drying.
- the dried cordyceps may be milled into a powder from 30 to 200 mesh size, and more preferably in 50 to 100 mesh size.
- cordyceps extract When cordyceps extract is prepared by the method described above, a cordyceps extract containing a high concentration of adenosine can be obtained, for instance a concentration of 100 mg to 220 mg of adenosine per 100g of cordyceps extract. This is much higher than the concentration of 25 mg/100g according to the previous methods of preparation ( Figure 1 and example 1 below) . In some embodiments, a concentration of adenosine higher than 110 mg/100g, and even higher than 150 mg/100g can be reached. The final concentration of adenosine depends on the blanching conditions, including the blanching time and temperature, as well as the blanching steps.
- An aspect of the invention relates to a nutrition composition comprising a cordyceps extract obtainable by the method described above.
- the nutrition composition may be a food product, a drink, a functional food, a nutraceutical, a food additive, a nutritional formula, and a pet food product.
- the nutrition composition may be prepared by mixing the cordyceps extract into a standard nutritional product.
- the dry cordyceps extract can be dry-mixed into the dry nutritional product.
- the dry cordyceps extract can be mixed into milk powder.
- the invention provides the use of a cordyceps extract which contains an amount of adenosine ranging from 100 mg/100 g to 220 mg/100 g, for the preparation of a nutritional composition for the treatment or prevention of fatigue, of cardiovascular disease, or of inflammation, or for the improvement of immunity.
- the nutrition composition may be a food product, a drink, a functional food, a nutraceutical, a food additive, a nutritional formula, and a pet food product.
- the adenosine content was analysed by UPLC, as explained in Experimental example 6.
- the cordyceps powder contained 25 mg of adenosine per 100 g of powder.
- cordyceps slurry 50 g was collected and chopped in a miller to obtain a cordyceps slurry. 500g of water was added to the cordyceps slurry. The blanching was performed in two steps (indicated in grey boxes on Figure 2) : the cordyceps slurry was then treated for 3 hours (180 minutes) at 30°C (soaking) , and then, the cordyceps slurry was further treated at 85°C for 30 minutes. Finally, the cordyceps slurry was sterilized at 101°C for 10 minutes, and freeze-dried at -50°C overnight. The freeze-dried cordyceps was collected and milled as a brown powder.
- the adenosine content was analysed by UPLC, as explained in Experimental example 6.
- the cordyceps powder contained 176 mg of adenosine per 100g of powder.
- cordyceps slurry 50 g was collected and chopped in a miller to obtain a cordyceps slurry. 500g of water was added to the cordyceps slurry. The blanching was performed in two steps (indicated in grey boxes on Figure 3) : the cordyceps was then treated for 3 hours (180 minutes) at 30°C(soaking) , and then, the cordyceps slurry was further treated at 85°C for 30 minutes. Finally, the cordyceps slurry was freeze-dried at -50°C overnight. The freeze-dried cordyceps was collected and milled as a brown powder.
- the adenosine content was analysed by UPLC, as explained in Experimental example 6.
- the cordyceps powder contained 205 mg of adenosine per 100g of powder.
- the blanched cordyceps slurry was not sterilised, contrary to Example 2. It seems that sterilisation has a negative impact on the adenosine content.
- cordyceps slurry 50 g was collected and chopped in a miller to obtain a cordyceps slurry. 500g of water was added to the cordyceps slurry. The blanching was performed in one step (indicated in a grey box on Figure 4) : the cordyceps slurry was treated for 30 minutes at 85°C. Finally, the cordyceps slurry was sterilized at 101°C for 10 minutes, and freeze-dried at -50°Covernight. The freeze-dried cordyceps was collected and milled as a brown powder.
- the adenosine content was analysed by UPLC, as explained in Experimental example 6.
- the cordyceps powder contained 109 mg of adenosine per 100g of powder.
- a one-step blanching was used, contrary to Examples 2 and 3. It seems that a one-step blanching yields a lower adenosine content than a two-step blanching.
- cordyceps slurry 50 g was collected and chopped in a miller to obtain a cordyceps slurry. 500g of water was added to the cordyceps slurry. The blanching was performed in one step (indicated in a grey box on Figure 5) : the cordyceps slurry was treated for 180 minutes at 30°C. Finally, the cordyceps slurry was sterilized at 101°C for 10 minutes, and freeze-dried at -50°Covernight. The freeze-dried cordyceps was collected and milled as a brown powder.
- the adenosine content was analysed by UPLC, as explained in Experimental example 6.
- the cordyceps powder contained 158 mg of adenosine per 100g of powder.
- a one-step mild blanching was used, contrary to Example 4. It seems that a mild blanching yields a higher adenosine content than a stronger blanching.
- fine cordyceps extract powder was extracted by methanol : water (1:1, v/v) under ultrasonic condition for 30 minutes and quantified by UPLC-PDA with a C18 column (for instance, Acquity BEH C18, 2.1*100 mm, 1.7 um) .
- the analysis was performed with isocratic method at room temperature at a flow speed of 1.0 ml/minutes.
- the mobile phase was water : methanol (95:5, v/v) .
- the absorption wavelength for quantification was 259.4 nm.
- the cordyceps extract is analysed by Acquity UPLC-PDA (Waters, USA) . Detailed parameters of UPLC are shown in the table below:
- FIG. 6 is an example of a chromatogram of cordyceps extract by UPLC-PDA
- the concentration of adenosine was calculated according to the standard curve created by injecting different level of standards. For example, the standards listed below were injected to get the calibration curve.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A method for preparing cordyceps extract containing adenosine in high concentration is disclosed. The extract contains from 100 mg to 220 mg of adenosine per 100 g. The extract may be used for the preparation of a nutritional composition for the treatment of prevention of fatigue, of cardiovascular disease, or of inflammation, or for the improvement of immunity.
Description
The invention relates to a method for preparing a cordyceps extract. More particularly, the invention relates to a method for preparing a cordyceps extract containing adenosine in high concentration.
Any discussion of the prior art throughout the specification should in no way be considered as an admission that such prior art is widely known or forms part of common general knowledge in the field.
Cordyceps is a genus of ascomycete fungi that grow mainly on insects and other arthropods. Cordyceps is a well-known ingredient in traditional Chinese medicine. Cordyceps is also named DongChongXiaCao in Chinese or “caterpillar fungus” or “winter worm summer grass” in English. When used in traditional Chinese medicine, the ingredient consists in fact of the fungus together with the caterpillar it developed on. In the rest of the specification, the word “cordyceps” will refer to the traditional medicinal ingredient, as used in traditional Chinese medicine. When referring to a fungus specie, the name of the species or the genus will be capitalised and in italics, such as Cordyceps sinensis.
According to traditional Chinese medicine, cordyceps is commonly used as a tonic and for medicinal purposes, such as to replenish the kidney, to soothe the lung, and for the treatment of fatigue. Because of the rarity and outstanding curative effects of Cordyceps sinensis, several strains have been isolated from wild Cordyceps sinensis mycelium. These isolated strains are used in fermentation technology and they are commonly sold as functional food products. Quality control of C. sinensis and its products is very important to ensure their safety and efficacy. In addition, some substitutes such as C. . militaris and C. adulterants also have been used.
Cordyceps seems to be a source of interesting chemical constituents such as cordycepin (3'-de-oxyadenosine) , adenosine and its derivatives, ergosterol, or polysaccharides.
Adenosine is a purine nucleoside and plays an important role in biochemical processes, such as energy transfer —as adenosine triphosphate (ATP) and adenosine diphosphate (ADP) —as well as in signal transduction as cyclic adenosine monophosphate (cAMP) . It is also a neuromodulator to promote sleep and suppress arousal. Adenosine also plays a role in regulation of blood flow to various organs through vasodilation. Adenosine acts through several types of receptors which are located, for instance in the immune, nervous, circulatory, respiratory or urinary systems. It is suggested that adenosine and cordycepin are some of the bio-active compounds which provide the anti-inflammation, anti-oxidant and heart-protective effects of cordyceps.
Cordycepin (3'-deoxyadenosine) and adenosine are generally suggested as quality markers of cordyceps. Fresh cordyceps also contains high amount of water. Therefore, cordyceps must be dried for commercial purposes and long-time storage. Also, cordyceps used for food purposes must comply with regulatory requirements. For instance, in China, cordyceps products must contain at least 50 mg/100g of adenosine, and have a total plate count (TPC) below 10000.
Years of research have proven that the characteristic and nutritional components of cultured Cordyceps sinensis are the same as those of wild Cordyceps sinensis, if not higher. Additional studies showed that Cordyceps sinensis can be cultivated to produce spores which are considered as the best part of Cordyceps sinensis.
The traditional method of preparation of cordyceps includes drying, milling, sterilising and packing. However, the cordyceps extract prepared traditionally does not provide the required adenosine content and does not meet the microbiological safety standards. In order to have a high adenosine concentration in the finished products, suppliers have to be very considerate when selecting fresh cordyceps and
the processing parameters. However, these operations still do not guarantee the consistency of the product, especially a reproducible batch quality.
In addition, in order to eliminate microbiological risks, suppliers usually apply sterilization and irradiation. However, these operations may cause loss of adenosine or degradation of other active components, which in turn may cause compliance concerns.
It is desirable to overcome or ameliorate at least one of the disadvantages of the prior art, or to provide a useful alternative. In particular, it is desirable to provide a method to prepare a cordyceps extract with consistent batch quality, with sufficient adenosine content, and with a low microbiological contamination. It is also desirable that the cordyceps extract can be used easily in the preparation of food products, or beverages, such as functional food products.
SUMMARY OF THE INVENTION
The object of the invention is achieved by the subject matter of the independent claims. The dependent claims further develop the idea of the present invention.
Accordingly, in a first aspect, the invention provides a method for preparing a cordyceps extract comprising the steps of: a) grinding cordyceps, b) blanching said cordyceps, c) drying said blanched cordyceps, wherein blanching comprises a treatment of said cordyceps at a temperature of from 27℃ to 90℃ during 20 to 240 minutes in water.
In a second aspect, the invention provides a cordyceps extract prepared from a method according to the first aspect of the invention, wherein said cordyceps extract contains from 100 mg to 220 mg of adenosine per 100 g of extract.
In a third aspect, the invention provides a nutrition composition comprising a cordyceps extract obtainable by a method according to the first aspect of the invention, or a cordyceps extract according to the second aspect of the invention. The nutrition composition may be a food product, a drink, a functional food, a nutraceutical, a food additive, a nutritional formula, and a pet food product.
In a fourth aspect, the invention provides the use of a cordyceps extract according to the second aspect of the invention, or prepared by a method according to the first aspect of the invention, for the preparation of a nutritional composition for the treatment or prevention of fatigue, of cardiovascular disease, or of inflammation, or for the improvement of immunity.
These and other aspects, features and advantages of the invention will become more apparent to those skilled in the art from the detailed description of embodiments of the invention, in connection with the attached drawings.
Figure 1 is a flow chart showing the traditional preparation of cordyceps, as explained in example 1 (prior art) .
Figures 2 to 5 are flow charts showing embodiments of a method according to the invention, of preparing the cordyceps extract as explained in example 2 to 5.
Figure 6 is a chromatogram of cordyceps extract by UPLC-PDA, as further explained in Experimental example 6.
Throughout the specification, the words “comprise” , “comprising” and the like are to be construed in an inclusive sense, that is to say, in the sense of “including, but not limited to” , as opposed to an exclusive or exhaustive sense. As used in the specification, the singular forms “a” , “an” , and “the” include plural referents unless the context clearly dictates otherwise.
Unless noted otherwise, all percentages in the specification refer to weight percent.
Unless defined otherwise, all technical and scientific terms have and should be given the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
Cordyceps used herein refers to all Cordyceps species, including C. sinensis, C.militaris, C. capita, C. pruinosa and C. ophioglossoides. In an embodiment,
Cordyceps species are selected from the group consisting of C. sinensis, C. militaris, C.capita, C. pruinosa and C. ophioglossoides, preferably from C. sinensis, C. militaris and C. ophioglossoides.
When preparing the cordyceps extract according to the invention, a mix of cordyceps may be used, with different Cordyceps species, such as a mix of cordyceps which contains both Cordyceps sinensis and Cordyceps ophioglossoides. It is preferable that cordyceps is fresh. This way, the quality of the cordyceps extract is improved over dried cordyceps. However, it is also possible to prepare the cordyceps extract based on dried cordyceps.
Examples of methods for preparing a cordyceps extract are illustrated in Figures 2 to 5. In Figures 2 to 5, optional steps are indicated in dashed boxes. Grey boxes correspond to the blanching steps, as explained below.
In common to all the embodiments of the method of preparing a cordyceps extract, cordyceps is grinded into powder. Grinding can be performed in water, to obtain a cordyceps slurry direclty. Grinding increases the surface/volume ratio of the cordyceps particle, which improves the efficiency of extraction. Grinding can be achieved by chopping, cutting, or other methods. Preferably, the cordyceps is grinded to a particles size of 0.5mm to 5mm, more preferably of 1mm to 3mm. Preferably, fresh cordyceps is used, although dried cordyceps can also be used.
As shown on the process diagrams of Figures 2 to 5, water is added to the grinded cordyceps, to obtain a cordyceps slurry. As mentioned before, water can be also added to te cordyceps before grinding. There is no fixed weight ratio of cordyceps to water. Usually the cordyceps to water weight ratio ranges from 0.5:1 to 2:1, and preferably from 1:1 to 1.5:1. If less water is used, then the extraction may be less efficient. If too much water is used with respect to the cordyceps, then it will be necessary to evaporate the excess water, which will require a higher energy input. Water can be distilled water or tap water. Preferably, distilled water is used to reduce the risk of microbiological contamination, especially when the cordyceps extract is not sterilized.
The cordyceps slurry is then blanched in water. Blanching comprises a treatment of said cordyceps at a temperature of from 27℃ to 90℃ during 20 to 240 minutes in water. The inventors have found that blanching the cordyceps slurry improves the adenosine content of the cordyceps extract. The duration of the blanching step depends on the blanching temperature.
In some embodiments, blanching is performed in one step. For instance, the cordyceps slurry is blanched at a temperature of from 30℃ to 85℃ during 30 minutes to 200 minutes, preferably at a temperature of from 30℃ to 45 ℃ during 120 minutes to 200 minutes. In an embodiment, the cordyceps slurry is blanched by soaking at a temperature of from 30℃ to 40℃ during 150 minutes to 200 minutes. In another embodiment, the cordyceps slurry is blanched at a temperature of from 70℃to 90 ℃ during 30 minutes to 60 minutes.
In other preferred embodiments, blanching is divided into two steps: a first step is a mild heat treatment, followed by a second step which is a stronger heat treatment, in water. For instance, the cordyceps slurry is first soaked at a temperature of 30℃ to 45℃ for 120 minutes to 200 minutes in water, then the slurry is heated to a temperature of from 70℃ to 90 ℃ for 30 to 60 more minutes in water. In another preferred embodiment, blanching of the cordyceps slurry performed by soaking the cordyceps slurry at a first temperature of from 30℃ to 45℃ for 120 minutes to 200 minutes in water, then increasing the temperature up to a second temperature of 70℃ to 90℃ within 5 to 15 minutes, and maintaining the second temperature for 30 to 45 minutes.
As will be shown in the examples, the inventors have found that soaking the cordyceps slurry for 180 min at 30℃ (mild heat treatment) , and then heating the cordyceps slurry 85℃ for 30 minutes (stronger heat treatment) , allows the preparation of an extract with the highest adenosine content.
Preferably, the blanched cordyceps slurry is sterilised before drying. Sterilization reduces potential contaminations and allows for an longer shelf-life of the product. The blanched cordyceps slurry is sterilized at a temperature of from 98℃ to 101℃ for 10 to 15 minutes, more preferably for about 15 minutes.
After sterilisation, the cordyceps slurry is dried, for instance by freeze-drying, oven-drying, or vacuum-drying. The dried cordyceps may be milled into a powder from 30 to 200 mesh size, and more preferably in 50 to 100 mesh size.
When cordyceps extract is prepared by the method described above, a cordyceps extract containing a high concentration of adenosine can be obtained, for instance a concentration of 100 mg to 220 mg of adenosine per 100g of cordyceps extract. This is much higher than the concentration of 25 mg/100g according to the previous methods of preparation (Figure 1 and example 1 below) . In some embodiments, a concentration of adenosine higher than 110 mg/100g, and even higher than 150 mg/100g can be reached. The final concentration of adenosine depends on the blanching conditions, including the blanching time and temperature, as well as the blanching steps.
An aspect of the invention relates to a nutrition composition comprising a cordyceps extract obtainable by the method described above. The nutrition composition may be a food product, a drink, a functional food, a nutraceutical, a food additive, a nutritional formula, and a pet food product. The nutrition composition may be prepared by mixing the cordyceps extract into a standard nutritional product. When dry nutritional products are considered, the dry cordyceps extract can be dry-mixed into the dry nutritional product. For instance, the dry cordyceps extract can be mixed into milk powder. When wet nutritional products are considered, it may be desirable to mix the blanched cordyceps slurry, maybe concentrated and sterilised, into the wet nutritional product, before sterilisation or heat treatment of the wet nutritional product.
In a fourth aspect, the invention provides the use of a cordyceps extract which contains an amount of adenosine ranging from 100 mg/100 g to 220 mg/100 g, for the preparation of a nutritional composition for the treatment or prevention of fatigue, of cardiovascular disease, or of inflammation, or for the improvement of immunity. The nutrition composition may be a food product, a drink, a functional food, a nutraceutical, a food additive, a nutritional formula, and a pet food product.
EXAMPLES
Example 1 –Traditional preparation of cordyceps
As shown on Figure 1, 50 g of fresh cordyceps fruiting body was collected and it was pasteurized at 101℃ for 10 minutes. Then the pasteurised cordyceps was freeze-dried at -50℃ for 12 hours. The freeze-dried cordyceps was collected and milled. A brown powder was obtained.
The adenosine content was analysed by UPLC, as explained in Experimental example 6. The cordyceps powder contained 25 mg of adenosine per 100 g of powder.
Example 2 –Preparation of a cordyceps extract
As shown on Figure 2, 50 g of fresh cordyceps fruiting body was collected and chopped in a miller to obtain a cordyceps slurry. 500g of water was added to the cordyceps slurry. The blanching was performed in two steps (indicated in grey boxes on Figure 2) : the cordyceps slurry was then treated for 3 hours (180 minutes) at 30℃ (soaking) , and then, the cordyceps slurry was further treated at 85℃ for 30 minutes. Finally, the cordyceps slurry was sterilized at 101℃ for 10 minutes, and freeze-dried at -50℃ overnight. The freeze-dried cordyceps was collected and milled as a brown powder.
The adenosine content was analysed by UPLC, as explained in Experimental example 6. The cordyceps powder contained 176 mg of adenosine per 100g of powder.
Example 3 –Preparation of a cordyceps extract
As shown on Figure 3, 50 g of fresh cordyceps fruiting body was collected and chopped in a miller to obtain a cordyceps slurry. 500g of water was added to the cordyceps slurry. The blanching was performed in two steps (indicated in grey boxes on Figure 3) : the cordyceps was then treated for 3 hours (180 minutes) at 30℃(soaking) , and then, the cordyceps slurry was further treated at 85℃ for 30 minutes. Finally, the cordyceps slurry was freeze-dried at -50℃ overnight. The freeze-dried cordyceps was collected and milled as a brown powder.
The adenosine content was analysed by UPLC, as explained in Experimental example 6. The cordyceps powder contained 205 mg of adenosine per 100g of powder. In Example 3, the blanched cordyceps slurry was not sterilised, contrary to Example 2. It seems that sterilisation has a negative impact on the adenosine content.
Example 4 –Preparation of a cordyceps extract
As shown on Figure 4, 50 g of fresh cordyceps fruiting body was collected and chopped in a miller to obtain a cordyceps slurry. 500g of water was added to the cordyceps slurry. The blanching was performed in one step (indicated in a grey box on Figure 4) : the cordyceps slurry was treated for 30 minutes at 85℃. Finally, the cordyceps slurry was sterilized at 101℃ for 10 minutes, and freeze-dried at -50℃overnight. The freeze-dried cordyceps was collected and milled as a brown powder.
The adenosine content was analysed by UPLC, as explained in Experimental example 6. The cordyceps powder contained 109 mg of adenosine per 100g of powder. In Example 4, a one-step blanching was used, contrary to Examples 2 and 3. It seems that a one-step blanching yields a lower adenosine content than a two-step blanching.
Example 5 –Preparation of a cordyceps extract
As shown on Figure 5, 50 g of fresh cordyceps fruiting body was collected and chopped in a miller to obtain a cordyceps slurry. 500g of water was added to the cordyceps slurry. The blanching was performed in one step (indicated in a grey box on Figure 5) : the cordyceps slurry was treated for 180 minutes at 30℃. Finally, the cordyceps slurry was sterilized at 101℃ for 10 minutes, and freeze-dried at -50℃overnight. The freeze-dried cordyceps was collected and milled as a brown powder.
The adenosine content was analysed by UPLC, as explained in Experimental example 6. The cordyceps powder contained 158 mg of adenosine per 100g of powder. In Example 5, a one-step mild blanching was used, contrary to Example 4. It seems that a mild blanching yields a higher adenosine content than a stronger blanching.
The table below summarises the main processing steps of examples 1-5 and compares the adenosine content of the milled cordyceps extract.
Experimental example 6 –Method of analysis of the adenosine content
Referring to the method from Chinese pharmacopeia, fine cordyceps extract powder was extracted by methanol : water (1:1, v/v) under ultrasonic condition for 30 minutes and quantified by UPLC-PDA with a C18 column (for instance, Acquity BEH C18, 2.1*100 mm, 1.7 um) . The analysis was performed with isocratic method at room temperature at a flow speed of 1.0 ml/minutes. The mobile phase was water : methanol (95:5, v/v) . The absorption wavelength for quantification was 259.4 nm.
The cordyceps extract is analysed by Acquity UPLC-PDA (Waters, USA) . Detailed parameters of UPLC are shown in the table below:
This method was used to analyse the adenosine content in the cordyceps extract described in Examples 1 to 5. Figure 6 is an example of a chromatogram of cordyceps extract by UPLC-PDA
The concentration of adenosine was calculated according to the standard curve created by injecting different level of standards. For example, the standards listed below were injected to get the calibration curve.
Standard name | Concentration (X value) | Adenosine Response (Y value) |
1 μg/mL mix standard | 1 μg/mL | 16415 |
2 μg/mL mix standard | 2 μg/mL | 29055 |
4 μg/mL mix standard | 4 μg/mL | 64063 |
8 μg/mL mix standard | 8 μg/mL | 130661 |
15 μg/mL mix standard | 15 μg/mL | 246860 |
30 μg/mL mix standard | 30 μg/mL | 476448 |
50 μg/mL mix standard | 50 μg/mL | 810322 |
Based on results above, a calibration equation for adenosine was obtained, such as Y=aX+b. Then unknown samples were injected to get response Y value and calculate X value in μg/mL. Finally the adenosine content A in the sample can be expressed in mg/100g according to the formula below:
X adenosine concentration (μg/mL) as calculated with the calibration equation
m sample weight (g)
50 dilution volume (mL)
1000 conversion factor from μg to mg
Claims (15)
- A method for preparing a cordyceps extract comprising the steps of:a) grinding cordyceps,b) blanching said cordyceps,c) drying said blanched cordyceps,wherein blanching comprises a treatment of said cordyceps at a temperature of from 27℃ to 90℃ during 20 to 240 minutes in water.
- A method according to claim 1, wherein blanching is performed at a temperature of from 30℃ to 85℃ during 30 minutes to 200 minutes.
- A method according to claim 1 or 2, wherein blanching is performed by soaking said cordyceps at a temperature of from 30℃ to 45℃ during 120 minutes to 200 minutes.
- A method according to claim 1, wherein blanching is performed at a temperature of from 70℃ to 90℃ during 30 minutes to 60 minutes.
- A method according to claim 1, wherein blanching is performed by soaking the cordyceps at a temperature of 30℃ to 45℃ for 120 minutes to 200 minutes in water, then heating the cordyceps to a temperature from 70℃ to 90℃ for 30 to 60 minutes in water.
- A method according to claim 1, wherein blanching is performed by soaking the cordyceps at a first temperature of 30℃ to 45℃ for 120 minutes to 200 minutes in water, then increasing the temperature up to a second temperature of 70℃ to 90℃ within 5 to 15 minutes, and maintaining the second temperature for 30 to 45 minutes.
- A method according to any one of claims 1 to 6, wherein said water and cordyceps are in a weight ratio of from 0.5: 1 to 2: 1, preferably from 1: 1 to 1.5: 1.
- A method according to any one of claims 1 to 7, which comprises a step of sterilising at a temperature of 98℃ to 101℃ for 10 to 15 minutes between the blanching step and the drying step.
- A method according to any one of claims 1 to 8, wherein the drying step is performed by freeze-drying, oven–drying, or vacuum-drying.
- A method according to any one of claims 1 to 9, which comprises a further step of milling after the drying step.
- A method according to any one of claims 1 to 10, wherein said cordyceps is Cordyceps militaris or Cordyceps sinensis.
- A cordyceps extract prepared from a method according to any one of claims 1 to 11, wherein said cordyceps extract contains from 100 mg to 220 mg of adenosine per 100 g of extract.
- A nutrition composition comprising a cordyceps extract obtainable according to any one of claims 1 to 11 or a cordyceps extract according to claim 12.
- A nutrition composition according to claim 13, wherein said nutrition composition is selected from the group consisting of a food product, a drink, a functional food, a nutraceutical, a food additive, a nutritional formula, and a pet food product.
- Use of a cordyceps extract obtainable according to any one of claims 1 to 11 or a cordyceps extract according to claim 12, for the preparation of a nutritional composition for the treatment or prevention of fatigue, of cardiovascular disease, or of inflammation, or for the improvement of immunity.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2014/095955 WO2016106704A1 (en) | 2014-12-31 | 2014-12-31 | A process for preparing a cordyceps extract |
CN201580071335.5A CN107105736A (en) | 2014-12-31 | 2015-12-21 | The method for preparing Cordyceps |
PCT/EP2015/080757 WO2016107776A1 (en) | 2014-12-31 | 2015-12-21 | A process for preparing cordyceps extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2014/095955 WO2016106704A1 (en) | 2014-12-31 | 2014-12-31 | A process for preparing a cordyceps extract |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016106704A1 true WO2016106704A1 (en) | 2016-07-07 |
Family
ID=55025073
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2014/095955 WO2016106704A1 (en) | 2014-12-31 | 2014-12-31 | A process for preparing a cordyceps extract |
PCT/EP2015/080757 WO2016107776A1 (en) | 2014-12-31 | 2015-12-21 | A process for preparing cordyceps extract |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2015/080757 WO2016107776A1 (en) | 2014-12-31 | 2015-12-21 | A process for preparing cordyceps extract |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN107105736A (en) |
WO (2) | WO2016106704A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107475128A (en) * | 2017-09-08 | 2017-12-15 | 吉林省天祺蛹虫草繁育研究有限公司 | A kind of production method of selenium-rich cordyceps |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018133835A1 (en) * | 2017-01-20 | 2018-07-26 | National Institute Of Biological Sciences, Beijing | Nucleoside analogue regulating mammalian circadian rhythm |
CN112401290B (en) * | 2020-09-25 | 2022-03-11 | 山东省食品发酵工业研究设计院 | Preparation method of tobacco Chinese caterpillar fungus strips |
CN112868705A (en) * | 2021-02-05 | 2021-06-01 | 山西省农业科学院食用菌研究所 | Radix seu herba Gei aleppici nutrient element and preparation process thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1151699A (en) * | 1994-06-30 | 1997-06-11 | 明治乳业株式会社 | Health compsn. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101690463B (en) * | 2009-08-21 | 2012-06-27 | 吉林大学 | Mutagenic strain of cordyceps militaris and breeding method |
CN101928317B (en) * | 2010-08-13 | 2012-11-21 | 内蒙古昆明卷烟有限责任公司 | Extraction of active ingredients of cordyceps sinensis and application of active ingredients to cigarettes |
KR20140001319A (en) * | 2012-06-26 | 2014-01-07 | 동아대학교 산학협력단 | Manufacturing method of cordyceps militaris extracts and pharmaceutical composition or health assistance food comprising the extracts for anti-cancer |
CN103652832A (en) * | 2012-09-25 | 2014-03-26 | 江苏学府生物工程有限公司 | Micronizing technology of wildly-cultivated cordyceps militaris fruit body |
CN103238826A (en) * | 2013-05-23 | 2013-08-14 | 东方中科生命科学有限责任公司 | Production method capable of improving absorption and utilization rates of cordyceps sinensis and preparation of method |
-
2014
- 2014-12-31 WO PCT/CN2014/095955 patent/WO2016106704A1/en active Application Filing
-
2015
- 2015-12-21 WO PCT/EP2015/080757 patent/WO2016107776A1/en active Application Filing
- 2015-12-21 CN CN201580071335.5A patent/CN107105736A/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1151699A (en) * | 1994-06-30 | 1997-06-11 | 明治乳业株式会社 | Health compsn. |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107475128A (en) * | 2017-09-08 | 2017-12-15 | 吉林省天祺蛹虫草繁育研究有限公司 | A kind of production method of selenium-rich cordyceps |
Also Published As
Publication number | Publication date |
---|---|
WO2016107776A1 (en) | 2016-07-07 |
CN107105736A (en) | 2017-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kalac | Edible mushrooms: chemical composition and nutritional value | |
KR100884044B1 (en) | The manufacturing process of extrusion and fermented red ginseng and mountain ginseng extracts | |
WO2016106704A1 (en) | A process for preparing a cordyceps extract | |
JP2017042125A (en) | Cordyceps militaris having various efficacy, and production method thereof | |
CN107638560A (en) | A kind of preparation method of edible fungi active peptide | |
KR102025260B1 (en) | Method of Making Bamboo Fermented Extract | |
Soudy et al. | Effects of traditional soaking on the nutritional profile of taro flour (Colocasia esculenta L. Schott) produced in Chad | |
Leung et al. | Vitamins D and D 2 in Cultivated Mushrooms under Ultraviolet Irradiation and Their Bioavailability in Humans: A Mini-Review | |
KR102119227B1 (en) | Method for Manufacturing Fermented Seasoning Using Oyster Mushroom | |
Karima et al. | Storage biologically active substances by convection drying food and medicinal plants. | |
KR101462310B1 (en) | method for lentinula edodes extracts and the extract | |
KR101220131B1 (en) | An enzymatically treated brown rice and process for preparing thereof | |
CN107997125A (en) | Edible mushroom mycelium and or edible mushroom mycelium powder manufacture craft and products thereof | |
KR102326975B1 (en) | Production method of traditional soybean paste of low salt using shitake mushroom and Dendropanax morbifera LEV and of spread jam using this | |
CN110607245B (en) | Lucid ganoderma cordyceps sinensis capsule and preparation method thereof | |
CN108740790A (en) | A kind of sauce beans and preparation method thereof | |
KR20100100144A (en) | Mokcho sap powder composition comprising lavender oil powder and mokcho sap patch using the same | |
CN105622256A (en) | Cultivation method of ganoderma lucidum antler substitute material | |
CN105347987A (en) | Culture medium for substitute cultivation of ganoderma lucidum antler | |
Abdul-Malek et al. | Beneficial properties of edible mushrooms and their potential utilisation of mushroom waste in food products | |
KR100913963B1 (en) | Method for manufacture of black aged garlic using elvan | |
JP2002272267A (en) | Method for artificially culturing plant worm and extracted composition of isaria japonica and functional food using the same | |
KR102313188B1 (en) | Honey Composition comprising Ganoderma Lucidum and Manufacturing Method thereof | |
KR102477517B1 (en) | Complexed culture method of 6 types of mushroom mycelium using gastrodia elata blume medium | |
Kotnala et al. | Medicova: nutritional and medicinal value of mushroom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14909512 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14909512 Country of ref document: EP Kind code of ref document: A1 |